Vimarsana
Biggest News Aggregation in the World

Page 48 - Cigna Corp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cigna Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cigna Corp Today - Breaking & Trending Today

US seeks to understand role of middlemen in pricing pharmacy drugs - Vimarsana News

US seeks to understand role of middlemen in pricing pharmacy drugs

The U.S. Federal Trade Commission said it is probing how big pharmacy benefit managers, such as at CVS Caremark, are influenced in terms of pricing and patients' access to medications

Federal regulators probe Cigna's pharmacy benefit manager, CVS Caremark, and others. What are they investigating? – Hartford Courant - Vimarsana News

Federal regulators probe Cigna's pharmacy benefit manager, CVS Caremark, and others. What are they investigating? – Hartford Courant

“Although many people have never heard of pharmacy benefit managers, these powerful middlemen have enormous influence over the U.S. prescription drug system,” FTC Chair Lina M. Khan said this week.

Surging Drug Prices Targeted in US Study of Pharmacy Giants - Vimarsana News

Surging Drug Prices Targeted in US Study of Pharmacy Giants

The U.S. Federal Trade Commission is looking into how big pharmacy benefit managers like CVS Caremark affect pricing ...

FTC Probe Into Rx Middlemen May Spark Industry Shakeup - Vimarsana News

FTC Probe Into Rx Middlemen May Spark Industry Shakeup

Concerns that pharmaceutical middlemen inflate drug prices and harm patients have led the Federal Trade Commission to launch a probe into the largely unregulated industry, and legal experts say the move could unwind long-settled mergers and open companies up to prosecution.

Source: law360.com
FTC looking into how OptumRx, other pharmacy benefit managers affect drug prices - Vimarsana News

FTC looking into how OptumRx, other pharmacy benefit managers affect drug prices

The Federal Trade Commission has sent the companies, also including CVS Caremark and Prime Therapeutics, demands for information. The probe also is looking at how the managers affect access to prescription drugs.